Evidence map›Paper›PMID 41748914›Full record

ArticleCommunications medicine2026

Explainable deep learning framework incorporating medical knowledge for insulin titration in diabetes.

Haowei He, Zhen Ying, Biao Li, Yujuan Fan, Ping Wang, Jiaping Lu, Liming Wu, Hexu Zhao, Yanying Guo, Guangyu Wang and 3 more

Abstract read
In one paragraph

Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Haowei He *IIIS, Tsinghua University, Beijing, China.
Zhen Ying *Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
Biao LiShanghai Qi Zhi Institute, Shanghai, China.ORCID http://orcid.org/0009-0002-6080-3780
Yujuan FanMinistry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
Ping WangDepartment of Endocrinology and Metabolism, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Jiaping LuDepartment of Endocrinology and Metabolism, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, China.
Liming WuDepartment of Endocrinology and Metabolism, Shanghai Xuhui Central Hospital, Shanghai, China.
Hexu ZhaoIIIS, Tsinghua University, Beijing, China.
Yanying GuoDepartment of Endocrinology and Metabolic Diseases, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Diabetes, Urumqi, China.
Guangyu WangState Key Laboratory of Networking and Switching Technology, Beijing University of Posts and Telecommunications, Beijing, China. guangyu.wang24@gmail.com.ORCID http://orcid.org/0000-0003-1312-884X
Yang YuanIIIS, Tsinghua University, Beijing, China. yuanyang@mail.tsinghua.edu.cn.
Ying ChenMinistry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China. chen.ying4@zs-hospital.sh.cn.ORCID http://orcid.org/0000-0002-5209-3670
Xiaoying LiMinistry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.

Funding

Science and Technology Commission of Shanghai Municipality (Shanghai Municipal Science and Technology Commission) No. 23Y11904800
6 · The paper itself

Abstract

backgroundDeep learning has shown promise in diabetes management but faces challenges in real-world application due to its "black-box" nature, characterized by opaque internal decision-making processes. Explainable artificial intelligence (XAI) methods have been proposed to enhance model transparency. However, most of current XAI methods applied in the medical field often ignore the interaction of features in complex environments and pose deviation from clinical domain knowledge.

methodsOur study used two Electronic Health Record (EHR) cohorts of hospitalized patients with type 2 diabetes (T2DM), including an internal dataset of 1,275 inpatients (mean age 58.5 ± 14.3 years) and an external dataset of 292 patients (mean age 69.3 ± 14.5 years). We introduce an expert-guided XAI framework to improve the transparency and trustworthiness of deep learning models for insulin titration in diabetes management. The framework utilizes a post-hoc XAI model named Shapley Taylor Interaction Index (STII) to capture the impact of feature interactions. Additionally, the model is refined iteratively in a doctor-in-the-loop (DIL) process by encoding clinical constraints to align with medical expertise.

resultsHere we show that our STII-DIL model could explore the interaction factors and reduce unreasonable explanations compared with other explanation models. The final XAI system explanations demonstrated strong alignment with experts' explanations and increased correctness by expert evaluation An AI-human collaboration study revealed that insulin titration accuracy significantly improved for junior clinicians with STII-DIL assistance, while senior clinicians showed minimal change. Both junior and senior clinicians reported increased confidence when using the STII-DIL system.

conclusionsWe present an explainable deep learning framework that combines post-hoc XAI and expert domain knowledge to provide transparent and expert-aligned explanations for insulin titration in type 2 diabetes management. This framework enhances decision-making accuracy and confidence, especially for junior clinicians, and may facilitate broader clinical adoption of AI-assisted decision-making tools.

Identifiers

PMID41748914
PMCPMC13062103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.